Go to deals
Healthcare

PAUL HARTMANN AG has acquired Whitestone Acquisition Corp.

The private shareholders of Whitestone Acquisition Corp. have sold the company to PAUL HARTMANN AG (HARTMANN). Financial details have not been disclosed.

HARTMANN, headquartered in Heidenheim, Germany, is a worldwide leader in wound management, incontinence management and risk prevention products in the operating room. Together with the existing US subsidiary, HARTMANN-Conco, Inc. in Rock Hill, South Carolina, HARTMANN consolidates its position in the nursing home and home care sector, the most important market for incontinence products. With this acquisition, the USA will become the third largest market for HARTMANN after Germany and France. The company also sees great opportunities for the establishment of system solutions for inpatient and outpatient care.

Whitestone Acquisition Corp., based in Bloomington, Indiana, is a manufacturer of high-quality adult disposable incontinence products such as briefs, liners and underpads. Formed in 1995, Whitestone annually produces and distributes products for over US$40 million. The corporation primarily serves the institutional long-term care and healthcare markets, markets which are growing 7% a year due to demographic trends.

Oaklins' team in Germany advised HARTMANN on the acquisition of Whitestone Acquisition Corp.

Parties

Talk to the deal team

Dr. Florian  von Alten

Dr. Florian von Alten

Managing Partner
Hamburg, Germany
Oaklins Germany

Related deals

A group of Chilean investors has acquired Farmacias Ahumada
Consumer & Retail | Healthcare

A group of Chilean investors has acquired Farmacias Ahumada

A group of Chilean investors has acquired Farmacias Ahumada S.A. from Walgreens Boots Alliance.

Learn more
Shield Therapeutics has completed a fundraising
Healthcare

Shield Therapeutics has completed a fundraising

Shield Therapeutics plc has raised funds to bolster the expansion of ACCRUFeR®, the sole FDA-approved therapy for iron deficiency and to drive the business. Additionally, it positions the company for further investments.

Learn more
Haydale Graphene Industries has completed a fundraising
Healthcare

Haydale Graphene Industries has completed a fundraising

Haydale Graphene Industries PLC has raised funds to continue to develop the ongoing commercialization of its proprietary HDPlas® plasma functionalization process.

Learn more